1. Epigenetics of Triple-Negative Breast Cancer via Natural Compounds
   Mohammed Kaleem et al, 2022, Current Medicinal Chemistry CrossRef
2. The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance
   Mark Sicking et al, 2023, Biomarker Research CrossRef
3. Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells
   Samia S. Messeha et al, 2022, International Journal of Molecular Sciences CrossRef
4. Network medicine based approach for identifying the type 2 diabetes, osteoarthritis and triple negative breast cancer interactome: Finding the hub of hub genes
   Ilhaam Ayaz Durrani et al, 2024, Heliyon CrossRef
5. Clinical significance of the CXCL8/CXCR1/R2 signalling axis in patients with invasive breast cancer
   Sebastian Stępień et al, 2024, Oncology Letters CrossRef
6. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action
   Abdul Waheed Khan et al, 2022, Cells CrossRef
7. The potential roles of gossypol as anticancer agent: advances and future directions
   Danijela Paunovic et al, 2023, Chinese Medicine CrossRef